In Re (#06 June 2015)

Overcoming Challenges and Managing Risks in Pharmaceutical M&A

Olha O. Demianiuk

The healthcare sector was the most dominant industry in global M&A in 2014. In fact, 2014 was a record-breaking year for M&A in the healthcare sector, with deal values reaching USD 363 billion, 94% higher than those in 2013. Of those deals, almost 50% were cross-border transactions in which buyers acquired target companies or assets in countries outside their local markets.

The abstract/extract view of this article is free. Access to the full text of this article requires a subscription.

Please send subscription inquiries by:

Phone: +380 44 495-27-27
E-mail: subscribe@ujbl.info

Subscribe
The Ukrainian Journal of Business Law

Subscribe to The Ukrainian Journal of Business Law right now and enjoy the most relevant issues on doing business in Ukraine on your device or in print.

All this for just USD 9.99 a month.

 

Subscribe now